Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RPA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MIR3682 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
H2AFV - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PSMA4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CTSB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPA17 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC25A14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
METTL4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TNFRSF21 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GALM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAPGEF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPL17-C18orf32 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TCTEX1D2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POLR3GL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CREM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP2CB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
YPEL3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCDC127 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on